Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

kelly smith

- PMLiVE

Shire warms to Takeda’s latest offer, extending deadline

The new offer is £5 per share higher than Takeda’s opening bid

- PMLiVE

Otsuka finally gets FDA OK for kidney disease drug

Approval at last for rare disease treatment

- PMLiVE

Pfizer takes aim at UK’s health tech industry

Offers start-ups a share of a £56k grant

Shire Basingstoke

Morning brief: Takeda closes in on $64bn merger, GSK unveils team, and more

A rapid run-down of news in pharma, biotech and healthcare

It’s nice, but it’s not an infographic

If you want to know if you’ve created an infographic, you can have a go with our flow diagram

Cuttsy + Cuttsy

- PMLiVE

PureTech Health appoints new chief financial officer

Joep Muijrers joins the biopharma from Life Sciences Partners

Uncertainty, austerity and Brexit

What does it mean for the life science sector?

Pharma’s isolated islands of innovation

With service design and technology often failing the patient, why perspective on improving outcomes need to change

- PMLiVE

Will Shire agree to extend Takeda takeover talks?

UK rules mean Shire must agree to extend deadline

AstraZeneca AZ

AZ’s immuno-oncology combo fails another lung cancer trial

Latest failure casts doubt on company’s CTLA4 drug

- PMLiVE

Sanofi appoints ex-Roche Reed as new R&D head

John Reed to take up post after leaving Roche last month

- PMLiVE

FDA panel undermines Lilly and Incyte’s baricitinib hopes

Mixed review doesn’t bode well in competitive market

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links